Table of Contents Table of Contents
Previous Page  78 / 172 Next Page
Information
Show Menu
Previous Page 78 / 172 Next Page
Page Background

Abstracts of the 22

nd

National Congress of Digestive Diseases / Digestive and Liver Disease 48S2 (2016) e67–e231

e139

Material and methods:

From January 2011 to October 2014, all

consecutive patients with IPMN referred to our pancreatic disease

day service were enrolled and followed up with clinical visits, EUS

and/or MRI according to available guidelines.

Results:

A total of 41 patients, 16 males and 25 females (median

age: 68 years, range 35-87 years), with diagnosis of IPMN without

worrisome features were followed up for a median period of 38

months. At baseline clinical observation, all patients reported the

presence of abdominal pain and/or showed increased serum levels

of amilase and lypase. A family history of pancreatic cancer was

present in 3 patients whereas a personal history of malignancy

was present in 10 patients. Diagnosis of IPMN was reached by CT

scan in 14 patients, MRI in 20 patients, and EUS in 7 patients: 26

patients had a BD-IPMN, 6 patients a MD-IMPN, and 9 patients a

mixed type IPMN. During follow-up, 3/41 patients (7%) underwent

surgical resection due to a nodule (one mural intraductal and one

parenchimal) in two patients and an enlargement (>5 cm) of the

cystic lesion in another patient. IPMN features remained unmodified

in the remaining 38/41patients (93%). All three patients operated

had not family or personal history of malignancy.

Conclusions:

IPMN may progress toward pancreatic cancer. Patients

with IPMN should undergo careful surveillance, including EUS or

MRI, in order to promptly adopt a surgical strategy. Whether the

development and course of IPMN may be influenced by a family

history of pancreatic cancer and personal history of malignancy

remains to be clarified.

P.02.14

ACUTE PANCREATITIS IN ELDERLY PATIENTS: A RETROSPECTIVE

EVALUATION AT HOSPITAL ADMISSION

Losurdo G.*, Iannone A., Principi M., Barone M., Castellaneta N.M.,

Ranaldo N., Ierardi E., Di Leo A.

UO Gastroenterologia universitaria, Policlinico di Bari, Bari, Italy

Background and aim:

Acute pancreatitis (AP) in elderly may have

an aggressive course due to co-morbidity high rate and severe

presentation. We retrospectively evaluated AP severity and its

underlying factors in a group of elderly patients compared with an

adult population sample.

Material and methods:

Forty-two elderly patients (65-102 years)

and 48 controls (19-64 years) admitted at our Unit for biliary

or alcoholic AP were retrospectively enrolled. AP severity was

evaluated by Atlanta classification and Ransom score. Laboratory

investigations and demographic data were collected. Comparison

between the two groups was performed by t-test, ANOVA or Fisher’s

exact test. A multinomial logistic regression was used to determine

factors affecting AP severity.

Results:

Elderly patients showed more severe Atlanta score

(1.81±0.75 vs 1.29±0.46; p=0.007), as well as higher Ransom score

(2.52±1.57 vs 0.75±0.73; p<0.0001), even if no death was observed.

Elderly patients assumed more drugs than controls, and had a

higher rate of cardiovascular, pulmonary and renal co-morbidity.

They showed higher creatinine (1.09±0.41 vs 0.81±0.18; p=0.004)

and lower calcium levels (8.43±0.48 vs 8.88±0.44; p=0.002) than

controls. AP severity was influenced by white blood cell (WBC)

count (OR=1.94; 95% CI 1.14-2.86; p=0.048), aspartate-transaminase

(AST) levels (OR=1.97; 95% CI 1.91-2.18; p=0.02), serum lactate-

dehydrogenase (LDH) (OR=1.07; 95% CI 1.008-1.168; p=0.047) and

Ransom score (OR=70.4; 95% CI 45.7-134.8; p=0.036). The etiology

(biliary or alcoholic) did not influence the severity.

Conclusions:

Elderly patients usually undergo a severe AP course,

but without increase of mortality. High WBC, LDH, AST and Ransom

score at the onset may predict AP severity.

P.03 Endo/EUS 1

P.03.1

DIAGNOSTIC ACCURACY AND THERAPEUTIC IMPACT OF

EUS IN PATIENTS WITH INTERMEDIATE SUSPICION OF

CHOLEDOCHOLITHIASIS AND NEGATIVE MRCP

Grassia R.*

1

, Capone P.

2

, Staiano T.

1

, Rispo A.

2

, Iiritano E.

1

, Bianchi G.

1

,

Imperatore N.

2

, Buffoli F.

1

1

A.O. “Istituti Ospitalieri di Cremona”, Cremona, Italy,

2

A.O. Policlinico

“Federico II”, Napoli, Italy

Background and aim:

Endoscopic ultrasonography (EUS) and

magnetic resonance cholangiography (MRCP) are accurate proce­

dures in diagnosing common bile duct stones, thus suggesting

the possibility to avoid invasive endoscopic retrograde cholangio­

pancreatography. MRCP is non-invasive diagnostic procedure but its

accuracy decreases in presence of microlithiasis.

Aim:

To study the diagnostic accuracy and the therapeutic impact of

EUS in patients with intermediate likelihood of choledocholithiasis

and negative MRCP.

Material and methods:

Between January 2013 and August 2015,

all consecutive patients with clinical intermediate suspicion of

choledocholithiasis according to the ASGE guidelines and undergone

a negative MRCP for lithiasis, were retrospectively reviewed.

Sensitivity, specificity,

positive predictive value (PPV), negative

predictive value (NPV) and diagnostic accuracy of EUS, carried out

within 7 days of the initial clinical presentation, were determined.

Also, the clinicalimpactof EUS in the management of these patients

was assessed.

Results:

A total of 53 patients were included in the study. EUS

detected choledocholithiasis in 17 out of 53 patients with negative

MRCP. The subsequent ERCP confirmed lithiasis in 16 out of 17

patients (94%). Thus, EUS showed a diagnostic accuracy of 98% for

detection of CBD stones. Sensitivity, specificity, positive predictive

value, negative predictive value were: 100% (95% C.I. 74-100%), 97,3%

(95% C.I. 85-99%), 94% (95% C.I. 71-99%) and 100% (95% C.I. 90-100%),

respectively. The diagnostic gain of EUS compared to MRCP was 32%

with an EUS/MRCP agreement of about 70% (k=0.68, p <0.01).

Conclusions:

EUS is a highly accurate diagnostic tool for the common

bile duct stones detection. EUS findings change the management of

patients with intermediate suspicion of choledocholithiasis and a

negative MRCP allowing the diagnosis of lithiasis in 1/3 of them.

P.03.2

IS THERE A LINK BETWEEN PERIAMPULLARY DIVERTICULA AND

BILIOPANCREATIC DISEASES? AN EUS APPROACH TO ANSWER

THE QUESTION

Bruno M., Fasulo R.*, Gaia S., Marietti M., Ribaldone D.G., Risso A.,

Stradella D., Strona S., Rizzetto M., De Angelis C.

Gastroeneterologia ed Endoscopia Digestiva, Città della Salute e della

Scienza di Torino, Ospedale S. Giovanni Battista, Università di Torino,

Torino, Italy

Background and aim:

The prevalence of periampullary diverticula

(PAD) varies in literature from 0.16 to 27%. Many studies, all in

an ERCP setting, have been conducted to establish if a link exists

between PAD and biliopancreatic diseases but contradictory results

were obtained and the issue is still debated.

Material and methods:

We retrospectively reviewed our EUS

database from January 2001 to December 2014 enrolling patients

scheduled for EUS with an indication that entailed the exploration

of the second duodenum. Oblique viewing (50-55 degrees)

echoendoscopes from Olympus were employed. For each patient